Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis
暂无分享,去创建一个
D. Gladman | A. Cortes | J. Reveille | M. Weisman | M. Ward | M. Brown | M. Stone | A. Morgan | P. Rahman | P. Danoy | L. Gensler | T. Learch | M. Corr | W. Maksymowych | H. Marzo-Ortega | R. Inman | Bryan Paul Wordsworth
[1] M. Dougados,et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study , 2013, Annals of the rheumatic diseases.
[2] Tae-Hwan Kim,et al. HLA-B27 homozygosity has no influence on radiographic damage in ankylosing spondylitis: Observation Study of Korean spondyloArthropathy Registry (OSKAR) data. , 2013, Joint, bone, spine : revue du rhumatisme.
[3] Peter Donnelly,et al. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci , 2013, Nature Genetics.
[4] M. Dougados,et al. SAT0248 Evolution of Radiographic Damage in Ankylosing Spondylitis Over 12 Years of Follow-Up , 2013 .
[5] M. Weisman,et al. Cervical Vertebral Squaring in Patients without Spondyloarthritis , 2012, The Journal of Rheumatology.
[6] Antonio Martínez,et al. Genetic polymorphisms inside and outside the MHC improve prediction of AS radiographic severity in addition to clinical variables. , 2012, Rheumatology.
[7] P. Chang,et al. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis , 2012, Arthritis Research & Therapy.
[8] Daniel L. Koller,et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture , 2012, Nature Genetics.
[9] P. Rahman,et al. Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohort. , 2012, Arthritis and rheumatism.
[10] M. Dougados,et al. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis , 2012, Annals of the rheumatic diseases.
[11] E. Märker-Hermann,et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort , 2012, Annals of the rheumatic diseases.
[12] Jing Wu,et al. A genome-wide association study in Han Chinese identifies new susceptibility loci for ankylosing spondylitis , 2011, Nature Genetics.
[13] Antonio Martínez,et al. ERAP1 polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population. , 2011, Rheumatology.
[14] Paul Weston,et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility , 2011, Nature Genetics.
[15] M. González-Gay,et al. Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease , 2011, Arthritis research & therapy.
[16] M. Brown,et al. Promise and pitfalls of the Immunochip , 2011, Arthritis research & therapy.
[17] William D Fraser,et al. Genome wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone , 2010, Nature Genetics.
[18] Michael M. Ward,et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci , 2010, Nature Genetics.
[19] J. Malley,et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. , 2009, Arthritis and rheumatism.
[20] E. Lee,et al. Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis. , 2009, Clinical and experimental rheumatology.
[21] M. Dougados,et al. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine , 2008, Annals of the rheumatic diseases.
[22] Kari Stefansson,et al. Multiple genetic loci for bone mineral density and fractures. , 2008, The New England journal of medicine.
[23] A. Skytthe,et al. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation , 2008, Scandinavian journal of rheumatology.
[24] Zhaohui S. Qin,et al. A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.
[25] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[26] J Tuomilehto,et al. Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis , 2005, Annals of the rheumatic diseases.
[27] M. Dougados,et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. , 2005, Arthritis and rheumatism.
[28] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[29] M. A. van 't Hof,et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system , 2004, Annals of the rheumatic diseases.
[30] L. Bradbury,et al. Concordance of disease severity among family members with ankylosing spondylitis? , 2004, The Journal of rheumatology.
[31] L. Cardon,et al. Is disease severity in ankylosing spondylitis genetically determined? , 2001, Arthritis & Rheumatism.
[32] R. Wallace,et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis , 2000, Nature Genetics.
[33] W. Dougall,et al. RANK is essential for osteoclast and lymph node development. , 1999, Genes & development.
[34] R. Steinman,et al. TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell Activation , 1999, The Journal of experimental medicine.
[35] P Wordsworth,et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. , 1997, Arthritis and rheumatism.
[36] A. Cats,et al. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. , 1984, Arthritis and rheumatism.
[37] Boersma Jw. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. , 1976 .
[38] J. Boersma. Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone. , 1976, Scandinavian journal of rheumatology.